Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.17/1777
Título: Long-Term and Concentration-Dependent Beneficial Effect of Efavirenz on HDL-Cholesterol in HIV-Infected Patients
Autor: Pereira, SA
Branco, T
Côrte-Real, R
Germano, I
Lampreia, F
Caixas, U
Monteiro, E
Palavras-chave: CHLC MED
Benzoxazinas
Colesterol
Colesterol HDL
Relação Dose-Resposta a Medicamento
Estudos de Follow-Up
Glicoproteínas
Infecção por HIV
HIV-1
Oxazinas
Estudos Prospectivos
Inibidores de Transcriptase Reversa
Factores de Tempo
Resultado de Tratamento
Data: 2006
Editora: Wiley
Citação: Br J Clin Pharmacol. 2006 May;61(5):601-4
Resumo: AIMS: To investigate the long-term effects of efavirenz on cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein (LDL-C) and triglycerides (TG). METHODS: Thirty-four HIV-infected patients who commenced efavirenz therapy were monitored for 36 months. RESULTS: In patients with baseline HDL-C<40 mg.dL-1 an increase in HDL-C from 31+/-1 mg.dL-1 to 44+/-2 mg.dL-1 (95% confidence interval 5.9, 21.9, P<0.01) was observed and remained throughout the follow-up period. Median efavirenz plasma concentration was 1.98 mg.L-1 and a direct correlation between percentage of HDL-C variation or TC/HDL-C ratio and efavirenz plasma concentrations was found. CONCLUSIONS: There is evidence of a long-term and concentration-dependent beneficial effect of efavirenz on HDL-C in HIV-infected patients.
Peer review: yes
URI: http://hdl.handle.net/10400.17/1777
Aparece nas colecções:MED - Artigos

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
BJCP 2006 601.pdf123,96 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.